Skip to main content
. 2018 Dec 17;2018:3810108. doi: 10.1155/2018/3810108

Figure 2.

Figure 2

Gynecologic cancer cells with GOF TP53 are highly sensitive to proteasome inhibitors alone or in combination with LBH589/panobinostat. Sensitivity (as measured by percent viability relative to untreated control) to bortezomib (a, b) or MLN2238/ixazomib (c, d) alone or in combination with LBH589/panobinostat was examined in KLE endometrial cancer cells with R175H GOF mutant (a, c) and OVCAR3 ovarian cancer cells with R248Q GOF mutant (b, d). The concentration of LBH589/panobinostat used in (a–d) was based on sensitivity to LBH589/panobinostat alone in KLE (e) and OVCAR3 (f) cells. All experiments were performed three times. ∗∗P < 0.01; ∗∗∗∗P < 0.0001 by two-way ANOVA with Sidak's multiple comparison test.